• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈部半透明厚度增加的21三体胎儿的宫内致死率。

Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.

作者信息

Hyett J A, Sebire N J, Snijders R J, Nicolaides K H

机构信息

Harris Birthright Research Centre for Fetal Medicine, King's College Hospital Medical School, London, UK.

出版信息

Ultrasound Obstet Gynecol. 1996 Feb;7(2):101-3. doi: 10.1046/j.1469-0705.1996.07020101.x.

DOI:10.1046/j.1469-0705.1996.07020101.x
PMID:8776233
Abstract

This study investigates whether first-trimester screening for trisomy 21 by fetal nuchal translucency thickness preferentially identifies those fetuses destined to die in utero and examines the potential impact of such a method of screening on the live birth incidence of trisomy 21. In 70 pregnancies, trisomy 21 was diagnosed at 12 (range 11-14) weeks of gestation and the parents opted for elective termination which was carried out at 14 (12-20) weeks. In all cases, viability was established by ultrasound scan at the time of chorion villus sampling (CVS) and just before termination of pregnancy. Eight (11.4%) fetuses died in the interval between CVS and termination of pregnancy and this rate of lethality was higher than the 6.9% estimated rate for an unselected population of trisomy 21 fetuses. This 4.5% increase may, in part, be attributed to the effects of CVS and may also be due to patient selection on the basis of increased nuchal translucency. The rate of lethality increased with translucency thickness from 5.3% for those with translucency of 1-3 mm to 23.5% for translucency of > 7 mm. In trisomy 21, the rate of intrauterine lethality is associated with nuchal translucency thickness. Nevertheless, a policy of screening by maternal age and fetal nuchal translucency followed by selective termination of affected fetuses would still result in a more than 70% reduction in the live birth incidence of trisomy 21.

摘要

本研究调查了通过胎儿颈部半透明厚度进行孕早期21三体综合征筛查是否会优先识别出那些注定会在子宫内死亡的胎儿,并探讨了这种筛查方法对21三体综合征活产发生率的潜在影响。在70例妊娠中,于妊娠12周(范围11 - 14周)诊断出21三体综合征,父母选择了选择性终止妊娠,于14周(12 - 20周)进行。在所有病例中,在绒毛取样(CVS)时以及即将终止妊娠前通过超声扫描确定胎儿存活能力。8例(11.4%)胎儿在CVS与终止妊娠之间的间隔期死亡,这一致死率高于未选择的21三体综合征胎儿群体估计的6.9%的致死率。这4.5%的增加部分可能归因于CVS的影响,也可能是由于基于颈部半透明性增加进行的患者选择。致死率随半透明厚度增加而上升,半透明厚度为1 - 3毫米者的致死率为5.3%,而半透明厚度大于7毫米者的致死率为23.5%。在21三体综合征中,子宫内致死率与颈部半透明厚度相关。然而,采用基于孕妇年龄和胎儿颈部半透明厚度进行筛查,随后对受影响胎儿进行选择性终止妊娠的政策,仍将使21三体综合征的活产发生率降低70%以上。

相似文献

1
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.颈部半透明厚度增加的21三体胎儿的宫内致死率。
Ultrasound Obstet Gynecol. 1996 Feb;7(2):101-3. doi: 10.1046/j.1469-0705.1996.07020101.x.
2
Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.颈部半透明厚度增加的21三体胎儿的自然病史。
Ultrasound Obstet Gynecol. 1995 Jun;5(6):381-3. doi: 10.1046/j.1469-0705.1995.05060381.x.
3
First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.孕早期21三体胎儿的颈部透明带厚度及心脏间隔缺损情况
Am J Obstet Gynecol. 1995 May;172(5):1411-3. doi: 10.1016/0002-9378(95)90470-0.
4
Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.撒丁岛12495例妊娠中的胎儿颈部透明带筛查。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):649-51. doi: 10.1046/j.0960-7692.2001.00583.x.
5
Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.在普通产科人群中通过测量胎儿颈部透明带来筛查唐氏综合征。
Ultrasound Obstet Gynecol. 1998 Sep;12(3):163-9. doi: 10.1046/j.1469-0705.1998.12030163.x.
6
First-trimester fetal nuchal translucency thickness and risk for trisomies.孕早期胎儿颈部半透明厚度与三体综合征风险
Obstet Gynecol. 1994 Sep;84(3):420-3.
7
Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.通过胎儿颈部透明带厚度和孕妇年龄筛查21三体综合征:德国、奥地利和瑞士的一项多中心项目。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):645-8. doi: 10.1046/j.0960-7692.2001.00604.x.
8
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.孕11⁺⁰至13⁺⁶周时,通过胎儿三尖瓣反流、颈部透明带以及母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白-A筛查21三体综合征。
Ultrasound Obstet Gynecol. 2006 Feb;27(2):151-5. doi: 10.1002/uog.2699.
9
Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.胎儿颈部透明带:孕早期超声筛查胎儿三体综合征
Br J Obstet Gynaecol. 1994 Sep;101(9):782-6. doi: 10.1111/j.1471-0528.1994.tb11946.x.
10
Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.1015例颈部透明带增厚胎儿的染色体缺陷与结局
Ultrasound Obstet Gynecol. 1995 Jan;5(1):15-9. doi: 10.1046/j.1469-0705.1995.05010015.x.

引用本文的文献

1
First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome.孕早期使用生化标志物妊娠相关血浆蛋白A(PAPP-A)和游离β-人绒毛膜促性腺激素(β-hCG)进行唐氏综合征、帕陶氏综合征和爱德华氏综合征的母体血清筛查。
Indian J Clin Biochem. 2013 Jan;28(1):3-12. doi: 10.1007/s12291-012-0269-9. Epub 2012 Oct 12.
2
Down's syndrome, cardiac anomalies, and nuchal translucency.唐氏综合征、心脏异常与颈部透明带厚度
BMJ. 1999 Jan 9;318(7176):70-1. doi: 10.1136/bmj.318.7176.70.